Clario’s eCOA innovations with Cogstate’s expertise in neuroscience to yield high quality endpoints

Below is a press release released yesterday,Posted for the sake of completeness. Interesting but in the near term not hugely significant, however it is easy to see the long-term benefits of becoming more embedded in the Clario ecosystem. FYI Clario is the new name for ERT after its merger with Bioclincia.


Collaboration combines Clario’s eCOA innovations with Cogstate’s expertise in neuroscience to yield high quality endpointsPHILADELPHIA, PA – May 20, 2022 –

Clario, a technology company that delivers the leading endpoint solutions for decentralized (DCT), hybrid and site-based clinical trials, announced today, on World Clinical Trials Day, an expansion of its partnership with cognitive science company, Cogstate, to jointly provide data quality solutions to support the unique requirements of neuroscience assessments for therapeutic development.

The collaboration drives enhanced data quality and signal detection for the full range of conventional cognitive endpoints common in neuroscience studies. It combines Clario’s eCOA Multimedia technology for audio, photo and patient/clinician data capture with Cogstate’s global clinical network and deep therapeutic expertise in neurodegenerative diseases.

This expands the companies’ previously announced partnership to deliver Cogstate’s digital cognitive assessments with Clario’s eCOA platform offering a dramatically streamlined solution for digital and conventional outcomes with an integrated approach to hardware, training and operational support.“Clinical trials, particularly those in neurodegenerative disease, require sensitive, reliable endpoints that are delivered with a streamlined, patient-centric approach, integrating the range of clinical assessments across performance-based, clinician-reported and patient-reported outcomes,” said Andrew Cooper, Executive Vice President, eCOA and Trial Enablement at Clario. “Fit-for-purpose eCOA functionality such as photo and audio capture and advanced workflow and scoring automations enable reliable and standardized data collection for cognitive endpoints when tightly coupled with industry-leading rater training and monitoring. That is what Cogstate and Clario have come together to deliver.”

“We are thrilled to expand our partnership with the eCOA experts at Clario to support the full range of cognitive and clinical assessments critical to neuroscience research,” said Brad O’Connor, Chief Executive Officer at Cogstate. “As a company, we have pioneered digital assessments of cognition as well as novel delivery models for rater training of conventional cognitive assessments. Effectively balancing data quality benefits with operational ease can only be achieved when you combine deep domain expertise with capable and flexible clinical systems. This expanded collaboration offers an approach that can meaningfully reduce rater and site burden while driving quality outcomes.” Clinical Trials can transform and save lives. This partnership will continue to drive innovation for clinicians and patients.

To learn more about Clario’s eCOA Multimedia, please navigate to the Clario website.